Cardiology

There is a known connection between atrial fibrillation and stroke risk. Finding the best way to handle this connection can determine the success of care and the quality of life for patients.

Patients diagnosed with atrial fibrillation will often need treatment extending over a long period of time. In many cases ablation can be the best way to manage their symptoms requiring the work of an electrophysiologist.

At The European Society of Cardiology Congress 2016 (ESC), Ibrahim Danad, MD, VU University Medical Center, Amsterdam, Netherlands, explained the results from his team's PACIFIC trial, which assessed two non-invasive coronary artery imaging tools: positon emission tomography (PET) and single photon emission computed tomography (SPECT).

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Anselm Gitt, MD discussed the DYSIS program, which was designed to get an idea to see how patients were treated for secondary prevention, focusing on dyslipidemia patients.

Renato Delascio Lopes, MD, Duke University Medical Center, discussed at the European Society of Cardiology Congress 2016 (ESC), the progress of anticoagulant therapies for patients.

Christopher Granger, MD, Duke University Medical Center also spoke at the European Society of Cardiology COngress 2016 about the issues surrounding patients' tolerability of anticoagulants and other drugs.

Statins should not be physicians' first option in treating all patients at high risk of cardiovascular disease, according to new European treatment guidelines.

An international team looked at oral anticoagulants and decided dabigatran is the best for stroke prevention in non-valvular atrial fibrillation.

Lung cancer patients who develop sinus tachycardia due to some treatments for their cancer can successfully reduce their heart rates with ivabradine, researchers in Romania report.

Pope Francis plans to appear at the ESC Congress 2016 to endorse the group's healthy lifestyle campaign.

Poushali Mukherjea, PhD, Executive Director, Global Medical Affairs, Bristol-Myers Squibb, noted some key takeaways from her team's 19 abstracts slated to be presented at the European Society of Cardiology Congress 2016 (ESC).

While some patients may need procedures like gastric bypass surgery to lose weight others may be able to achieve their goals by taking smaller steps.

If peripheral artery disease is not caught soon enough patients risk losing toes, feet, or legs to amputation. Going from the beginning of the treatment process through potential amputation is a delicate balancing act for doctors.

Diagnosing peripheral artery disease can be a simple process if doctors know what they are looking for and patients follow medical directions.

A new analysis finds that patients taking warfarin for their atrial fibrillation are more likely to develop dementia than those taking the drug for treatment of other conditions.

There are many patients around the world suffering from various degrees of heart failure. With such potentially fatal consequences there has been a push to make the condition only treated by specialists.

When most people think of palliative care their first thought is likely to hospice and end of life oncology care, but experts in the field are working to change and expand that perception to other areas of health care as well.

Study results show that newly initiated combined antiretroviral therapy (ART) in treatment-naïve patients with HIV appears to not effectively prevent the progression of significant arterial inflammation.

Researchers have found a treasure trove of information posted by people on Facebook, Twitter and other online forums. Is it ethical, legal, or scientifically valid to create research studies using such postings?

It's time to redirect the initial evaluation of low- to intermediate-risk patients presenting with symptoms suggestive of CAD back to the primary care and internal medicine setting.

The approval of medications like statins and PCSK9 inhibitors to help lower cholesterol levels have proven helpful but a recent study looked at whether patients were getting not only the treatments they needed but whether they were getting the right dosage levels to help improve their health.

There have been several guidelines published in recent years about the proper blood pressure levels for patients with hypertension and how best to avoid the condition altogether. Weighing these guidelines in practice can be a challenge for physicians and patients alike.

As new medications are introduced to the market there can be some hesitation by doctors to make the jump from more traditional treatment options. Moving beyond that has shown benefits for a patient's long term health.